Consistent with the previous studies, we found that interfering with HER2 could inhibit the phosphorylation of p38 and Erk in HER2 + IBC tumour cells, as well as the expression of PTN (Extended Data Fig. S12l). This evidence concerns the gene ERBB2 and neoplasm.